期刊文献+

抗纤复方对硬变肝原代培养肝细胞超微结构的影响 被引量:3

Effect of Anti-fibrosis Compound Prescription on Ultrastructure of Primary Cultured Fibrous Hepatocytes
下载PDF
导出
摘要 观察抗纤复方对硬变肝原代培养肝细胞超微结构的影响。以 0 5 %二甲基亚硝胺 (DMN)予大鼠腹腔注射造成肝纤维化模型。分为小牛血清对照、正常大鼠血清对照、抗纤复方药物血清和抗纤复方药物原液 4个观察组 ,通过电镜进行细胞超微结构观察。结果 ,抗纤复方两组的纤维肝肝细胞基本完整 ,代谢活跃。抗纤复方有稳定肝细胞膜及促进细胞光面内质网的解毒功能 ,同时有抑制纤维肝肝细胞过量合成胶原的作用。 Objective :To observe the effect of anti fibrosis compound prescription(ACP) on ultrastructure of primary cultured fibrous hepatocytes. Methods :0 5% of dimethylnitrosamine (DMN) was injected intraperitoneally to rats to make hepatic fibrosis models.Four groups were divided to be examined by electron microscopy. Results :The fibrous hepatocytes of two ACP groups were almost intact and metabolically active. Conclusion :ACP can stabilize the membranes of hepatocytes and promote detoxification of smooth endoplasmic reticulum.Simultaneously,ACP can also inhibit the excessive production of collagens of fibrous hepatocytes.
出处 《辽宁中医杂志》 CAS 2001年第11期699-700,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助课题 ( 39670 90 6)
关键词 抗纤复方 肝纤维化 原代培养 肝细胞 超微结构 中医药治疗 anti fibrosis compound prescription liver fibrosis primary culture hepatocyte ultrastructure
  • 相关文献

参考文献2

二级参考文献2

  • 1冷欣夫,科学通报,1986年,31卷,19期,1505页
  • 2赵三妹,中华病理学杂志,1987年,16卷,4期,260页

共引文献141

同被引文献37

  • 1张斌,万谟彬,王灵台.肝纤维化大鼠TGF-β_1与TIMP-1 mRNA的表达及补肾柔肝方的治疗作用[J].中西医结合学报,2004,2(4):274-277. 被引量:9
  • 2Liu P, Liu CH, Wang HN, et al. Effeet of salvianolic acid B on collagen production and mitogen - activated protein kinase activity in rat hepatic steilate cells[ J]. Aeta Pharmacol Sin, 2002; 23 : 733 - 738.
  • 3Jamall IS.Asimple method to determine nanogram levels of 4 - hydroxyproline in biological tissues [ J]. Analytical biochemistry, 1981 ; 112:70 - 75.
  • 4Pinzani M,Marra F,Carloni V. Cytokine receptors and signaling in hepatic stellate cells[ J ]. Semin Liver Dis, 2001,21 (3) :397 - 416.
  • 5Kanzier S,Lohse AW, keii A,et al. TGF - betai in liver fibrosis: an induchic transgenic mouse model to study liver fibrogrnesis[J] .Am J Physiol, 1999,276(4) : 1059 - 1065.
  • 6Friedman SL. Molecular mechanimls of hepatic fibrosis and principles therapy[J] .J Gastroenterol, 1997,32:424 - 430.
  • 7Lamireau T, Desmouliere A, Bioulac - Sage P, et al. Mechanisms of hepatic fibrogenesis[ J]. Arch Pediatr, 2002; 9: 392 - 405.
  • 8Housset C, Guechot J. Hepatic fibrosis: physiopathology and biological diagnosis[J]. Pathol Biol (Paris), 1999;47:886 - 894.
  • 9Albania E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy[J] .Clin Liver Dus,2001 ;5:315 - 334.
  • 10Levy MT, Mc Caughan GW, Marinos G, et al. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection[J]. Liver, 2002 ; 22 : 93 -101.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部